P1216 EFFICACY AND SAFETY OF SIMEPREVIR PLUS PEG-INTERFERON/RIBAVIRIN THERAPY IN PATIENTS WITH HCV GENOTYPE 1 – COMPARISON WITH TELAPREVIR PLUS PEG-INTERFERON/RIBAVIRIN THERAPY AND PEG-INTERFERON/RIBAVIRIN THERAPY.

Authors :: Nakajima, T.
Kimura, M.
Arakawa, T.
Kuwata, Y.
Ozeki, I.
Sato, T.
Ohmura, T.
Hige, S.
Karino, Y.
Toyota, J.
Source :: Journal of Hepatology. Apr2014 Supplement, Vol. 60, pS494-S494. 1p.
Publication Year :: 2014

Subjects :: *HEPATITIS C
*HEPATITIS C treatment
*RIBAVIRIN
*THERAPEUTIC use of interferons
*MEDICATION safety
*DRUG efficacy
*PATIENTS

Full Text Access

Tools